Alternative polyadenylation in cancer: Molecular mechanisms and clinical application

Ying Zhang1, Zikun Huang2, Weiqing Lu3

  • 1Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, No.7 Raoping Road, Shantou, Guangdong 515041, China; Clinical Research Center, Cancer Hospital of Shantou University Medical College, No.7 Raoping Road, Shantou, Guangdong 515041, China.

Insights

Alternative polyadenylation (APA) regulates gene expression by creating mRNA variants, controlled by RNA-binding proteins (RBPs). Dysregulation of APA and RBPs is linked to cancer, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Alternative polyadenylation (APA) is a key posttranscriptional regulatory mechanism generating diverse mRNA isoforms.
  • RNA-binding proteins (RBPs) control APA by binding to specific pre-mRNA sequences or structures.
  • Dysregulation of APA and RBPs is implicated in diseases like cancer, cardiovascular, and nervous system disorders.

Purpose of the Study:

  • To review current knowledge on APA mechanisms and the roles of RBPs.
  • To highlight advancements in high-throughput sequencing and bioinformatics for studying APA.
  • To explore the pathological role of APA dysregulation in oncogenesis and therapeutic potential.

Main Methods:

  • Literature review of APA mechanisms and RBP functions.
  • Evaluation of high-throughput sequencing and bioinformatics tools for genome-wide APA analysis.
  • Analysis of pathological consequences of APA dysregulation in cancer.

Main Results:

  • APA generates mRNA diversity, crucial for gene expression regulation.
  • RBPs are central regulators of APA, influencing mRNA isoform production.
  • Aberrant APA events contribute to tumor heterogeneity and cancer progression.
  • APA dysregulation impacts cell proliferation, invasion, metastasis, and therapy response.

Conclusions:

  • APA and RBPs play critical roles in normal cellular processes and disease, particularly cancer.
  • Targeting APA machinery and RBPs offers potential for novel cancer diagnostics and therapeutics.
  • Further research into APA-RBP interactions can lead to innovative treatment strategies for various cancers.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K